Retatrutide is a groundbreaking innovation by Eli Lilly, designed to revolutionize metabolic health. This triple hormone receptor agonist activates GLP-1, GIP, and glucagon receptors simultaneously. Unlike previous drugs targeting fewer pathways, Retatrutide offers a more effective solution for metabolic regulation, promising better outcomes for conditions like diabetes and obesity. Experience a comprehensive approach to metabolic wellness with Retatrutide.
Retatrutide is a groundbreaking innovation by Eli Lilly, designed to revolutionize metabolic health. This triple hormone receptor agonist activates GLP-1, GIP, and glucagon receptors simultaneously. Unlike previous drugs targeting fewer pathways, Retatrutide offers a more effective solution for metabolic regulation, promising better outcomes for conditions like diabetes and obesity. Experience a comprehensive approach to metabolic wellness with Retatrutide.
| Weight | .6 kg |
|---|---|
| MG | 10, 13, 20, 30 |
Reviews
There are no reviews yet.